Next Generation Tissue Biomarkers Global Market Report 2025

Description

Next-generation tissue biomarkers are sophisticated biological indicators derived from tissue samples that provide highly detailed and accurate insights into biological conditions. They capture subtle molecular and cellular changes within tissues, enabling a deeper understanding of physiological and pathological processes. These biomarkers are identified using advanced analytical techniques that allow for comprehensive examination of tissue characteristics.

The primary types of next-generation tissue biomarkers include genomic biomarkers, proteomic biomarkers, epigenetic biomarkers, transcriptomic biomarkers, and metabolomic biomarkers. Genomic biomarkers, based on DNA or RNA, help detect, diagnose, or predict disease risk and treatment responses by analyzing genetic mutations or expression patterns. Supporting technologies for these biomarkers include immunohistochemistry, next-generation sequencing, mass spectrometry-based proteomics, spatial biology platforms, digital pathology integrated with artificial intelligence, and others. These biomarkers find applications in areas such as oncology, companion diagnostics, drug discovery and development, neurology, and more, serving end users including hospitals, reference laboratories, pharmaceutical and biotechnology companies, academic and research institutions, and contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The next generation tissue biomarkers market research report is one of a series of new reports from The Business Research Company that provides next generation tissue biomarkers market statistics, including the next generation tissue biomarkers industry's global market size, regional shares, competitors with the next generation tissue biomarkers market share, detailed next generation tissue biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the next generation tissue biomarkers market. This next generation tissue biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The next generation tissue biomarkers market size has grown rapidly in recent years. It will grow from $2.68 billion in 2024 to $3.03 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth during the historic period can be attributed to increasing demand for personalized medicine, expanding adoption of immunohistochemistry techniques, a growing emphasis on early disease detection, rising healthcare expenditure, advancements in diagnostic imaging technologies, heightened awareness of biomarker-based diagnostics, and an increasing focus on companion diagnostics.

The next generation tissue biomarkers market size is expected to see rapid growth in the next few years. It will grow to $4.89 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to rising demand for multiplex biomarker assays, increasing adoption of next-generation sequencing, growing investment in cancer research, expanding applications of digital pathology, enhanced use of AI in diagnostics, a surge in clinical trials for targeted therapies, and broader availability of tissue-based genomic data. Major trends during the forecast period include advancements in next-generation sequencing, integration of artificial intelligence (AI) in digital pathology, development of advanced mass spectrometry-based proteomics, improvements in ribonucleic acid biomarker detection technologies, and integration with cloud-based data platforms.

The rising demand for personalized medicine is driving growth in the next-generation tissue biomarkers market. Personalized medicine tailors treatments based on an individual's genetic profile, lifestyle, and environmental factors. Its adoption is increasing due to advancements in genomic technologies, which enable highly specific and individualized treatment strategies. Next-generation tissue biomarkers support personalized medicine by providing precise information on a patient's tissue profile, guiding tailored therapies. For example, according to the Personalized Medicine Coalition, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022, including seven cancer drugs and three for other conditions. This rising demand for personalized medicine is therefore fueling the growth of the next-generation tissue biomarkers market.

Companies in this market are focusing on genomic-based diagnostic assays and sequencing solutions to improve precision and efficiency in cancer diagnostics and treatment. These tools examine genetic information to identify disease-related biomarkers, enabling more personalized diagnostic and therapeutic approaches. For instance, in August 2024, Illumina Inc., a US-based biotechnology company, received FDA approval for its TruSight Oncology Comprehensive test and two companion diagnostics. The test profiles over 500 genes from a single tissue sample, automates biomarker detection, and supports 24/7 deployment, significantly reducing turnaround times and improving clinical efficiency for targeted cancer therapies.

In July 2025, Quanterix Corporation, a US-based life sciences company, acquired Akoya Biosciences Inc. This acquisition aims to integrate Akoya's spatial biology capabilities into Quanterix's blood-based biomarker platform, enhancing tissue-to-blood precision diagnostics. Akoya Biosciences provides advanced solutions for analyzing next-generation tissue biomarkers, and this partnership strengthens Quanterix's technological depth in precision diagnostics.

Major players in the next generation tissue biomarkers market are Roche Diagnostics, Thermo Fisher Scientific Inc., LabCorp., Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Myriad Genetics Inc., NeoGenomics Laboratories Inc., Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc., PathAI Inc., Biocartis Group NV, Personalis Inc., Ultivue Inc., Indica Labs Inc., Strata Oncology Inc., Genialis Inc., Alida Biosciences Inc., and Biofidelity Ltd.

North America was the largest region in the next generation tissue biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in next generation tissue biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the next generation tissue biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The next generation tissue biomarkers market consists of revenues earned by entities by providing services such as epigenomics analysis, single-cell analysis, and multiplex immunofluorescence. The market value includes the value of related goods sold by the service provider or included within the service offering. The next generation tissue biomarkers market also includes sales of diagnostic assays, reagents and antibodies, sequencing kits, imaging and staining systems, multiplex analysis platforms, and spatial biology instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next Generation Tissue Biomarkers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on next generation tissue biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next generation tissue biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next generation tissue biomarkers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Genomic Biomarkers; Proteomic Biomarkers; Epigenetic Biomarkers; Transcriptomic Biomarkers; Metabolomic Biomarkers
2) By Technology: Immunohistochemistry; Next-Generation Sequencing; Mass Spectrometry (Ms)-Based Proteomics; Spatial Biology Platforms; Digital Pathology And Artificial Intelligence Analysis; Other Technologies
3) By Application: Oncology; Companion Diagnostics; Drug Discovery And Development; Neurology; Other Applications
4) By End Use: Hospitals And Reference Labs; Pharma And Biotech Companies; Academic And Research Institutes; Contract Research Organizations
Subsegments:
1) By Genomic Biomarkers: Single Nucleotide Polymorphisms; Copy Number Variations; Gene Fusions
2) By Proteomic Biomarkers: Protein Expression Levels; Post-Translational Modifications; Protein-Protein Interactions
3) By Epigenetic Biomarkers: Histone Modification Patterns; Chromatin Remodeling Biomarkers; Non-Coding Ribonucleic Acid Regulation
4) By Transcriptomic Biomarkers: Long Non-Coding Ribonucleic Acids; Circular Ribonucleic Acids; Alternative Splicing Variants
5) By Metabolomic Biomarkers: Lipid Profiles; Amino Acid Signatures; Organic Acids
Companies Mentioned: Roche Diagnostics; Thermo Fisher Scientific Inc.; LabCorp.; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Bio-Techne Corporation; Myriad Genetics Inc.; NeoGenomics Laboratories Inc.; Guardant Health Inc.; Foundation Medicine Inc.; NanoString Technologies Inc.; PathAI Inc.; Biocartis Group NV; Personalis Inc.; Ultivue Inc.; Indica Labs Inc.; Strata Oncology Inc.; Genialis Inc.; Alida Biosciences Inc.; Biofidelity Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37834

1. Executive Summary

2. Next Generation Tissue Biomarkers Market Characteristics

3. Next Generation Tissue Biomarkers Market Trends And Strategies

4. Next Generation Tissue Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Next Generation Tissue Biomarkers Growth Analysis And Strategic Analysis Framework

5.1. Global Next Generation Tissue Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Next Generation Tissue Biomarkers Market Growth Rate Analysis
5.4. Global Next Generation Tissue Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Next Generation Tissue Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Next Generation Tissue Biomarkers Total Addressable Market (TAM)

6. Next Generation Tissue Biomarkers Market Segmentation

6.1. Global Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genomic Biomarkers
Proteomic Biomarkers
Epigenetic Biomarkers
Transcriptomic Biomarkers
Metabolomic Biomarkers
6.2. Global Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunohistochemistry
Next-Generation Sequencing
Mass Spectrometry (Ms)-Based Proteomics
Spatial Biology Platforms
Digital Pathology And Artificial Intelligence Analysis
Other Technologys
6.3. Global Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Companion Diagnostics
Drug Discovery And Development
Neurology
Other Applications
6.4. Global Next Generation Tissue Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Reference Labs
Pharma And Biotech Companies
Academic And Research Institutes
Contract Research Organizations
6.5. Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Genomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Nucleotide Polymorphisms (Snps)
Copy Number Variations (Cnvs)
Gene Fusions
6.6. Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Proteomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Protein Expression Levels
Post-Translational Modifications (Ptms)
Protein-Protein Interactions
6.7. Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Epigenetic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Histone Modification Patterns
Chromatin Remodeling Biomarkers
Non-Coding Ribonucleic Acid Regulation
6.8. Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Transcriptomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Long Non-Coding Ribonucleic Acids
Circular Ribonucleic Acids
Alternative Splicing Variants
6.9. Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Metabolomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lipid Profiles
Amino Acid Signatures
Organic Acids

7. Next Generation Tissue Biomarkers Market Regional And Country Analysis

7.1. Global Next Generation Tissue Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Next Generation Tissue Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Next Generation Tissue Biomarkers Market

8.1. Asia-Pacific Next Generation Tissue Biomarkers Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Next Generation Tissue Biomarkers Market

9.1. China Next Generation Tissue Biomarkers Market Overview
9.2. China Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Next Generation Tissue Biomarkers Market

10.1. India Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Next Generation Tissue Biomarkers Market

11.1. Japan Next Generation Tissue Biomarkers Market Overview
11.2. Japan Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Next Generation Tissue Biomarkers Market

12.1. Australia Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Next Generation Tissue Biomarkers Market

13.1. Indonesia Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Next Generation Tissue Biomarkers Market

14.1. South Korea Next Generation Tissue Biomarkers Market Overview
14.2. South Korea Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Next Generation Tissue Biomarkers Market

15.1. Western Europe Next Generation Tissue Biomarkers Market Overview
15.2. Western Europe Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Next Generation Tissue Biomarkers Market

16.1. UK Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Next Generation Tissue Biomarkers Market

17.1. Germany Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Next Generation Tissue Biomarkers Market

18.1. France Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Next Generation Tissue Biomarkers Market

19.1. Italy Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Next Generation Tissue Biomarkers Market

20.1. Spain Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Next Generation Tissue Biomarkers Market

21.1. Eastern Europe Next Generation Tissue Biomarkers Market Overview
21.2. Eastern Europe Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Next Generation Tissue Biomarkers Market

22.1. Russia Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Next Generation Tissue Biomarkers Market

23.1. North America Next Generation Tissue Biomarkers Market Overview
23.2. North America Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Next Generation Tissue Biomarkers Market

24.1. USA Next Generation Tissue Biomarkers Market Overview
24.2. USA Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Next Generation Tissue Biomarkers Market

25.1. Canada Next Generation Tissue Biomarkers Market Overview
25.2. Canada Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Next Generation Tissue Biomarkers Market

26.1. South America Next Generation Tissue Biomarkers Market Overview
26.2. South America Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Next Generation Tissue Biomarkers Market

27.1. Brazil Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Next Generation Tissue Biomarkers Market

28.1. Middle East Next Generation Tissue Biomarkers Market Overview
28.2. Middle East Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Next Generation Tissue Biomarkers Market

29.1. Africa Next Generation Tissue Biomarkers Market Overview
29.2. Africa Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Next Generation Tissue Biomarkers Market Competitive Landscape And Company Profiles

30.1. Next Generation Tissue Biomarkers Market Competitive Landscape
30.2. Next Generation Tissue Biomarkers Market Company Profiles
- 30.2.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. LabCorp. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Next Generation Tissue Biomarkers Market Other Major And Innovative Companies

31.1. Illumina Inc.
31.2. Bio-Rad Laboratories Inc.
31.3. QIAGEN N.V.
31.4. Bio-Techne Corporation
31.5. Myriad Genetics Inc.
31.6. NeoGenomics Laboratories Inc.
31.7. Guardant Health Inc.
31.8. Foundation Medicine Inc.
31.9. NanoString Technologies Inc.
31.10. PathAI Inc.
31.11. Biocartis Group NV
31.12. Personalis Inc.
31.13. Ultivue Inc.
31.14. Indica Labs Inc.
31.15. Strata Oncology Inc.

32. Global Next Generation Tissue Biomarkers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Next Generation Tissue Biomarkers Market

34. Recent Developments In The Next Generation Tissue Biomarkers Market

35. Next Generation Tissue Biomarkers Market High Potential Countries, Segments and Strategies

35.1 Next Generation Tissue Biomarkers Market In 2029 - Countries Offering Most New Opportunities
35.2 Next Generation Tissue Biomarkers Market In 2029 - Segments Offering Most New Opportunities
35.3 Next Generation Tissue Biomarkers Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer